{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:05:22Z","timestamp":1785582322978,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M750519"],"award-info":[{"award-number":["2024M750519"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2311202"],"award-info":[{"award-number":["2024YFC2311202"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015796","name":"Shanghai Lingjun Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102406"],"award-info":[{"award-number":["82102406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202568"],"award-info":[{"award-number":["82202568"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cmi.2025.10.027","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:06:46Z","timestamp":1762290406000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acquired resistance during short-course treatment for rifampicin-resistant tuberculosis"],"prefix":"10.1016","volume":"32","author":[{"given":"Xinchang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbo","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengzhong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yena","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.10.027_bib1","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"10.1016\/j.cmi.2025.10.027_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5588\/ijtldopen.24.0469","article-title":"Patient pathway analysis of rifampicin-resistant TB diagnostic and treatment delays","volume":"2","author":"Ge","year":"2025","journal-title":"IJTLD Open"},{"key":"10.1016\/j.cmi.2025.10.027_bib3","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2666-5247(20)30195-6","article-title":"Globally diverse Mycobacterium tuberculosis resistance acquisition: A retrospective geographical and temporal analysis of whole genome sequences","volume":"2","author":"Ektefaie","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.cmi.2025.10.027_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijid.2020.10.081","article-title":"Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis","volume":"102","author":"Liu","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2025.10.027_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac029","article-title":"Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: A systematic review","volume":"4","author":"Mallick","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.cmi.2025.10.027_bib6","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1056\/NEJMoa2117166","article-title":"A 24-week, all-oral regimen for rifampin-resistant tuberculosis","volume":"387","author":"Nyang\u2019wa","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.10.027_bib7","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0140-6736(22)02078-5","article-title":"Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): An open-label, multicentre, randomised, non-inferiority trial","volume":"400","author":"Goodall","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2025.10.027_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa2400327","article-title":"Oral regimens for rifampin-resistant, fluoroquinolone-susceptible tuberculosis","volume":"392","author":"Guglielmetti","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.10.027_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12879-021-05870-w","article-title":"Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): Study protocol for a randomized controlled trial","volume":"21","author":"Weng","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2025.10.027_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01770-2018","article-title":"Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: A prospective cohort study","volume":"53","author":"Sun","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2025.10.027_bib11","article-title":"A short, all-oral regimen for pre-extensively drug-resistant tuberculosis: A multicenter open-label single-arm study","author":"Li","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.10.027_bib12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","article-title":"Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: A retrospective cohort study","volume":"15","author":"Walker","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2025.10.027_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05166","article-title":"Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area","volume":"4","author":"Guerra-Assun\u00e7\u00e3o","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.cmi.2025.10.027_bib14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3389\/fmicb.2019.01741","article-title":"Evaluation of whole-genome sequence method to diagnose resistance of 13 anti-tuberculosis drugs and characterize resistance genes in clinical multi-drug resistance Mycobacterium tuberculosis isolates from China","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2025.10.027_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01832-22","article-title":"Rapid detection of extensive drug resistance by Xpert MTB\/XDR optimizes therapeutic decision-making in rifampin-resistant tuberculosis patients","volume":"61","author":"Chen","year":"2023","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2025.10.027_bib16","series-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","year":"2023"},{"key":"10.1016\/j.cmi.2025.10.027_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00131-9","article-title":"The catalogue of Mycobacterium tuberculosis mutations associated with drug resistance to 12 drugs in China from a nationwide survey: A genomic analysis","volume":"5","author":"Pei","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.cmi.2025.10.027_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13073-025-01458-0","article-title":"Advantages of updated WHO mutation catalog combined with existing whole-genome sequencing-based approaches for Mycobacterium tuberculosis resistance prediction","volume":"17","author":"Chen","year":"2025","journal-title":"Genome Med"},{"key":"10.1016\/j.cmi.2025.10.027_bib19","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/s41467-025-57174-1","article-title":"Multivariable regression models improve accuracy and sensitive grading of antibiotic resistance mutations in Mycobacterium tuberculosis","volume":"16","author":"Kulkarni","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2025.10.027_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01164-21","article-title":"Role of epistasis in amikacin, kanamycin, bedaquiline, and clofazimine resistance in Mycobacterium tuberculosis complex","volume":"65","author":"Vargas","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.10.027_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.3548","article-title":"Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance","volume":"48","author":"Desjardins","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.cmi.2025.10.027_bib22","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S2666-5247(23)00002-2","article-title":"Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: An in-vitro and in-silico data analysis","volume":"4","author":"Sonnenkalb","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.cmi.2025.10.027_bib23","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/jac\/dkaa136","article-title":"Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid","volume":"75","author":"Kadura","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.10.027_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002283","article-title":"Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid","volume":"3","author":"Timm","year":"2023","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.cmi.2025.10.027_bib25","first-page":"684","article-title":"Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline","volume":"72","author":"Villellas","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.10.027_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102747","article-title":"Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment","volume":"55","author":"Nimmo","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmi.2025.10.027_bib27","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJM199404283301702","article-title":"The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis","volume":"330","author":"Weis","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.10.027_bib28","first-page":"1974","article-title":"Mixed Mycobacterium tuberculosis-strain infections are associated with poor treatment outcomes among patients with newly diagnosed tuberculosis, independent of pretreatment heteroresistance","volume":"218","author":"Shin","year":"2018","journal-title":"J Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2500549X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2500549X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:41:03Z","timestamp":1773924063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2500549X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1198743X2500549X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.10.027","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired resistance during short-course treatment for rifampicin-resistant tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}